Cargando…
Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
Background: Glioblastoma (GBM) is the most common primary malignant intracranial tumor and closely related to metabolic alteration. However, few accepted prognostic models are currently available, especially models based on metabolic genes. Methods: The transcriptome data were obtained for all of th...
Autores principales: | Lei, Chuxiang, Chen, Wenlin, Wang, Yuekun, Zhao, Binghao, Liu, Penghao, Kong, Ziren, Liu, Delin, Dai, Congxin, Wang, Yaning, Wang, Yu, Ma, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176239/ https://www.ncbi.nlm.nih.gov/pubmed/34093788 http://dx.doi.org/10.7150/jca.53827 |
Ejemplares similares
-
Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External Validation
por: Chen, Wenlin, et al.
Publicado: (2023) -
Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials
por: Chen, Wenlin, et al.
Publicado: (2021) -
Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses
por: Zhao, Binghao, et al.
Publicado: (2020) -
Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period
por: Wang, Yaning, et al.
Publicado: (2021) -
Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)